ea0073oc9.5 | Oral Communications 9: Endocrine-Related Cancer | ECE2021
Fideline Bonnet
, Devingenteuil Clara
, Vaczlavik Anna
, Bessiene Laura
, Laguillier-Morizot Christelle
, Assié Guillaume
, Helen Mosnier-Pudar
, Terris Benoît
, Groussin Lionel
, Guibourdenche Jean
, Bertherat Jerome
IntroductionFasting trial remains the gold standard to confirm the diagnosis of insulinoma, based on low blood glucose level concomitant with inadequate high insulin level. However, diagnostic criteria are not consensual. Glycemia and insulin thresholds differ between the different consensus statements : endogenous hyperinsulism diagnosis relies on a glycemia < 3 mmol/l associated with an insulin level > 3 mUI/l in Endocrine Society guidelines (2009)...